Mono Clonal Spike

Mouse Monoclonal Anti-SARS Spike IgG
AB-17910 50 ug
EUR 562.8

Human IgG antibody Laboratories manufactures the mono clonal spike reagents distributed by Genprice. The Mono Clonal Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Monoclonal. Other Mono products are available in stock. Specificity: Mono Category: Clonal Group: Spike

True north Cryobox 5mLBlue
PK10
EUR 153.6

True north Cryobox 15mLNatural
PK10
EUR 212.4

True north Cryobox 15mLBlue
PK10
EUR 212.4

True north Cryobox 50mLNatural
PK10
EUR 210

True north Cryobox 50mLBlue
PK10
EUR 210

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

Spike information

Spike Neutralizing Antibody (Clone G10xA5) (SARS-CoV-2)
101327 100 µg
EUR 600
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience, #78339).

MS Soil Spike Std
SOILSP01 1L
EUR 1675.2

91 SOW Matrix Spike
CLPP-MS91 1ML
EUR 198

91-SOW Surr Spike
CLPP-S91H 1ML
EUR 84

Spike Glycoprotein Antibody
20-abx300551
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Spike S1 Neutralizing Antibody (SARS-CoV-2) (Clone: 414-2)
100792 100 µg
EUR 460
Description: Recombinant human monoclonal (clone 414-2) antibody recognizing the SARS-CoV-2 Spike S1 RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus.

Spike S1 Neutralizing Antibody (SARS-CoV-2) (Clone: 414-1)
100793 100 µg
EUR 485
Description: Recombinant human monoclonal (clone 414-1) antibody recognizing the SARS-CoV-2 Spike S1 RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus.

90-SOW MATRIX SPIKE
CLPP-MS90H 1ML
EUR 258

91-SOW Matrix Spike
CLPP-MS91H 1ML
EUR 103.2

Spike Neutralizing Antibody (Clone LxC1-G10) (SARS-CoV-2)
101246 100 µg
EUR 545
Description: This human monoclonal antibody recognizes SARS-CoV-2 full-length spike proteins in the native trimeric conformation. This antibody cross-reacts with the wildtype (BPS Bioscience #100728) as well as the Alpha B.1.1.7 (BPS Bioscience #510334), Beta B.1.351 (BPS Bioscience #510333), Beta B.1.351Δ242-244 (BPS Bioscience #101091), Gamma P.1 (BPS Bioscience #100989), Delta B.1.617.2 (BPS Bioscience #101147) and Delta Plus B.1.617.2.1 (BPS Bioscience #101165) variant spike trimers [Table of variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using BPS Bioscience Spike Trimer: ACE2 Inhibitor Screening Kits (available for purchase).

SARS (IN1) Spike Peptide
3221P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN1) Spike peptide

SARS (IN2) Spike Peptide
3223P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN2) Spike peptide

SARS (IN3) Spike Peptide
3225P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN3) Spike peptide

91 SOW Surrogate Spike
CLPP-S91 2ML
EUR 247.2

EPH Surrogate Spike Mix
NJDEP-EPH-SS 1ML
EUR 242.4

SARS-CoV Spike Protein
abx060655-1mg 1 mg
EUR 2030.4

SARS-CoV Spike Antibody
3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.